Table: Daito - 6-MTH group results

Daito Pharmaceutical

10/01/2025 06:31

Jan 10 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Nov 30, 2024        Nov 30, 2023     May 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             24.58               24.11            49.00    
                 (+2.0 pct)          (+3.2 pct)       (+4.5 pct)  
  Operating          1.47                2.29             3.50    
                 (-35.7 pct)         (-19.0 pct)      (-10.1 pct) 
  Recurring          1.47                2.31             3.50    
                 (-36.5 pct)         (-15.9 pct)      (-10.8 pct) 
  Net              908 mln               1.55             2.30    
                 (-41.5 pct)         (-11.9 pct)      (-30.2 pct) 
  EPS             59.39 yen           98.22 yen       150.39 yen  
  Ann Div                             60.00 yen        70.00 yen  
  -Q2 div         35.00 yen           30.00 yen                   
  -Q4 div                             30.00 yen        35.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T